Prime Medicine, Inc. (NASDAQ: PRME) reported Q1 EPS of ($0.28), $0.08 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $856 thousand.

For earnings history and earnings-related data on Prime Medicine, Inc. (PRME) click here.